Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo
more »
- Univ. of Bergen (Norway); Haukeland University Hospital, Bergen (Norway)
- Icahn School of Medicine at Mount Sinai, New York, NY (United States)
- The Scripps Research Inst., La Jolla, CA (United States)
- Washington Univ., St. Louis, MO (United States). School of Medicine
- Instituto Nacional de Enfermedades Respiratorias (Mexico)
- Instituto Nacional de Enfermedades Respiratorias (Mexico); TecSalud (Mexico). School of Medicine and Health Sciences
Neuraminidase (NA) is one of the two influenza virus surface glycoproteins, and antibodies that target it are an independent correlate of protection. However, our current understanding of NA antigenicity is incomplete. Here, in this work, we describe human monoclonal antibodies (mAbs) from a patient with a pandemic H1N1 virus infection in 2009. Two mAbs exhibited broad reactivity and inhibited NA enzyme activity of seasonal H1N1 viruses circulating before and after 2009, as well as viruses with avian or swine N1s. The mAbs provided robust protection from lethal challenge with human H1N1 and avian H5N1 viruses in mice, and both target an epitope on the lateral face of NA. In summary, we identified two broadly protective NA antibodies that share a novel epitope, inhibited NA activity, and provide protection against virus challenge in mice. Our work reaffirms that NA should be included as a target in future broadly protective or universal influenza virus vaccines.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- USDOE Office of Science (SC), Basic Energy Sciences (BES)
- Grant/Contract Number:
- AC02-06CH11357
- OSTI ID:
- 2423459
- Journal Information:
- Immunity, Journal Name: Immunity Journal Issue: 8 Vol. 56; ISSN 1074-7613
- Publisher:
- Cell PressCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge
Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient
Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers
Journal Article
·
Wed Jun 13 00:00:00 EDT 2018
· Journal of Virology
·
OSTI ID:1479030
Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient
Journal Article
·
Sat Jan 19 23:00:00 EST 2013
· Virology
·
OSTI ID:22150092
Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers
Journal Article
·
Mon Feb 09 19:00:00 EST 2015
· Nature Communications
·
OSTI ID:1245874